Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 89 articles:
HTML format
Text format



Single Articles


    March 2020
  1. ROGERS RF, Walton MI, Cherry DL, Collins I, et al
    CHK1 inhibition is synthetically lethal with loss of B-family DNA polymerase function in human lung and colorectal cancer cells.
    Cancer Res. 2020 Mar 11. pii: 0008-5472.CAN-19-1372.
    PubMed     Text format     Abstract available


  2. TIAN J, Lou J, Cai Y, Rao M, et al
    Risk SNP-mediated enhancer-promoter interaction drives colorectal cancer through both FADS2 and AP002754.2.
    Cancer Res. 2020 Mar 3. pii: 0008-5472.CAN-19-2389.
    PubMed     Text format     Abstract available


    November 2019
  3. PLANTUREUX L, Mege D, Crescence L, Carminita E, et al
    The interaction of platelets with colorectal cancer cells inhibits tumor growth but promotes metastasis.
    Cancer Res. 2019 Nov 14. pii: 0008-5472.CAN-19-1181.
    PubMed     Text format     Abstract available


  4. ZHOU J, Liu Y, Zhang Y, Li Q, et al
    Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer: a retrospective analysis.
    Cancer Res. 2019 Nov 1. pii: 0008-5472.CAN-19-1940.
    PubMed     Text format     Abstract available


    October 2019
  5. GRIGORYAN H, Schiffman C, Gunter MJ, Naccarati A, et al
    Cys34 Adductomics Links Colorectal Cancer with the Gut Microbiota and Redox Biology.
    Cancer Res. 2019 Oct 22. pii: 0008-5472.CAN-19-1529.
    PubMed     Text format     Abstract available


    September 2019
  6. PELULLO M, Nardozza F, Zema S, Quaranta R, et al
    Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains colorectal cancer progression and chemoresistance.
    Cancer Res. 2019 Sep 10. pii: 0008-5472.CAN-19-0145.
    PubMed     Text format     Abstract available


    August 2019
  7. MUKOHYAMA J, Isobe T, Hu Q, Hayashi T, et al
    miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells.
    Cancer Res. 2019 Aug 15. pii: 0008-5472.CAN-18-3544.
    PubMed     Text format     Abstract available


  8. XU J, Meng Q, Li X, Yang H, et al
    Long non-coding RNA MIR17HG promotes colorectal cancer progression via miR-17-5p.
    Cancer Res. 2019 Aug 13. pii: 0008-5472.CAN-18-3880.
    PubMed     Text format     Abstract available


    July 2019
  9. TOME M, Pappalardo A, Soulet F, Lopez JJ, et al
    Inactivation of proprotein convertases in T cells inhibits PD-1 expression and creates a favorable immune microenvironment in colorectal cancer.
    Cancer Res. 2019 Jul 29. pii: 0008-5472.CAN-19-0086.
    PubMed     Text format     Abstract available


  10. WU S, Sun H, Wang Y, Yang X, et al
    MALAT1 rs664589 polymorphism inhibits binding to miR-194-5p contributing to colorectal cancer risk, growth and metastasis.
    Cancer Res. 2019 Jul 16. pii: 0008-5472.CAN-19-0773.
    PubMed     Text format     Abstract available


  11. WANG YQ, Jiang DM, Hu SS, Zhao L, et al
    SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial-Mesenchymal Transition.
    Cancer Res. 2019;79:3542-3556.
    PubMed     Text format     Abstract available


    June 2019
  12. KAMAL Y, Schmit SL, Hoehn HJ, Amos CI, et al
    Transcriptomic differences between primary colorectal adenocarcinomas and distant metastases reveal metastatic colorectal cancer subtypes.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3945.
    PubMed     Text format     Abstract available


  13. WANG D, Fu L, Wei J, Xiong Y, et al
    PPARdelta mediates the effect of dietary fat in promoting colorectal cancer metastasis.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-19-0384.
    PubMed     Text format     Abstract available


  14. YU J, Wang S, Zhang Y, Huang J, et al
    TRIM67 activates p53 to suppress colorectal cancer initiation and progression.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3614.
    PubMed     Text format     Abstract available


  15. TACCONI C, Ungaro F, Correale C, Arena V, et al
    Activation of the VEGFC/VEGFR3 pathway induces tumor immune escape in colorectal cancer.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3657.
    PubMed     Text format     Abstract available


  16. INDARTE M, Puentes R, Maruggi M, Ihle NT, et al
    An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.
    Cancer Res. 2019;79:3100-3111.
    PubMed     Text format     Abstract available


    May 2019
  17. SANTIAGO I, Santinha J, Ianus A, Galzerano A, et al
    Susceptibility Perturbation MRI Maps Tumor Infiltration into Mesorectal Lymph Nodes.
    Cancer Res. 2019;79:2435-2444.
    PubMed     Text format     Abstract available


  18. SHEN A, Chen Y, Liu L, Huang Y, et al
    EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
    Cancer Res. 2019;79:2257-2270.
    PubMed     Text format     Abstract available


    April 2019
  19. COMBES E, Andrade AF, Tosi D, Michaud HA, et al
    Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) overcomes oxaliplatin resistance and promotes anti-tumor immunity in colorectal cancer.
    Cancer Res. 2019 Apr 15. pii: 0008-5472.CAN-18-2807.
    PubMed     Text format     Abstract available


  20. LOPES-RAMOS CM, Kuijjer ML, Ogino S, Fuchs CS, et al
    Correction: Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
    Cancer Res. 2019;79:2084.
    PubMed     Text format    


  21. WANG W, Yang J, Edin ML, Wang Y, et al
    Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis.
    Cancer Res. 2019;79:1822-1830.
    PubMed     Text format     Abstract available


  22. TRAVELLI C, Consonni FM, Sangaletti S, Storto M, et al
    Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells.
    Cancer Res. 2019;79:1938-1951.
    PubMed     Text format     Abstract available


  23. HUANG S, Wang Z, Zhou J, Huang J, et al
    EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.
    Cancer Res. 2019;79:2009-2020.
    PubMed     Text format     Abstract available


  24. YOKOYAMA Y, Lew ED, Seelige R, Tindall EA, et al
    Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
    Cancer Res. 2019;79:1996-2008.
    PubMed     Text format     Abstract available


  25. JAYAKUMAR A, Bothwell ALM
    RIPK3-Induced Inflammation by I-MDSCs Promotes Intestinal Tumors.
    Cancer Res. 2019;79:1587-1599.
    PubMed     Text format     Abstract available


    March 2019
  26. KATONA BW, Glynn RA, Paulosky KE, Feng Z, et al
    Combined menin and EGFR inhibitors synergize to suppress colorectal cancer via EGFR-independent and calcium-mediated repression of SKP2 transcription.
    Cancer Res. 2019 Mar 15. pii: 0008-5472.CAN-18-2133.
    PubMed     Text format     Abstract available


  27. VALERI N
    Streamlining Detection of Fusion Genes in Colorectal Cancer: Having "Faith" in Precision Oncology in the (Tissue) "Agnostic" Era.
    Cancer Res. 2019;79:1041-1043.
    PubMed     Text format     Abstract available


  28. BISHNUPURI KS, Alvarado DM, Khouri AN, Shabsovich M, et al
    IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
    Cancer Res. 2019;79:1138-1150.
    PubMed     Text format     Abstract available


  29. SALEM M, Wallace C, Velegraki M, Li A, et al
    GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon.
    Cancer Res. 2019;79:1178-1190.
    PubMed     Text format     Abstract available


  30. COCCO E, Benhamida J, Middha S, Zehir A, et al
    Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
    Cancer Res. 2019;79:1047-1053.
    PubMed     Text format     Abstract available


  31. LIU C, Banister CE, Buckhaults PJ
    Spindle assembly checkpoint inhibition can resensitize p53-null stem cells to cancer chemotherapy.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-3024.
    PubMed     Text format     Abstract available


  32. WEISNER J, Landel I, Reintjes C, Uhlenbrock N, et al
    Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer.
    Cancer Res. 2019 Mar 11. pii: 0008-5472.CAN-18-2861.
    PubMed     Text format     Abstract available


  33. LIU Y, Deguchi Y, Tian R, Wei D, et al
    Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.
    Cancer Res. 2019;79:954-969.
    PubMed     Text format     Abstract available


  34. RAJENDRAN P, Johnson G, Li L, Chen YS, et al
    Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
    Cancer Res. 2019;79:918-927.
    PubMed     Text format     Abstract available


    February 2019
  35. TAKEDA M, Koseki J, Takahashi H, Miyoshi N, et al
    Disruption of endolysosomal RAB5/7 efficiently eliminates colorectal cancer stem cells.
    Cancer Res. 2019 Feb 14. pii: 0008-5472.CAN-18-2192.
    PubMed     Text format     Abstract available


  36. SAPIENZA C
    Epigenetic Drift in Colorectal Cancer-It's Probably Later Than You Think.
    Cancer Res. 2019;79:437-438.
    PubMed     Text format     Abstract available


  37. OSHIMA G, Poli EC, Bolt MJ, Chlenski A, et al
    DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
    Cancer Res. 2019;79:650-662.
    PubMed     Text format     Abstract available


  38. LUEBECK GE, Hazelton WD, Curtius K, Maden SK, et al
    Implications of Epigenetic Drift in Colorectal Neoplasia.
    Cancer Res. 2019;79:495-504.
    PubMed     Text format     Abstract available


    January 2019
  39. SCHIAPPACASSE COCIO GV, Schiappacasse ED
    Is Adjuvant Chemotherapy Efficient in Colon Cancer with High Microsatellite Instability? A Look Towards the Future.
    Cancer Res. 2019 Jan 24. pii: 0008-5472.CAN-18-2991.
    PubMed     Text format     Abstract available


  40. TAN X, Tong J, Wang YJ, Fletcher R, et al
    BET inhibitors potentiate chemotherapy and killing of SPOP-mutant colon cancer cells via induction of DR5.
    Cancer Res. 2019 Jan 23. pii: 0008-5472.CAN-18-3223.
    PubMed     Text format     Abstract available


  41. SHEN J, Zhao W, Ju Z, Wang L, et al
    PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.
    Cancer Res. 2019;79:311-319.
    PubMed     Text format     Abstract available


    November 2018
  42. ZHANG C, Qu L, Lian S, Meng L, et al
    PRL-3 promotes ubiquitination and degradation of AURKA and colorectal cancer progression via dephosphorylation of FZR1.
    Cancer Res. 2018 Nov 29. pii: 0008-5472.CAN-18-0520.
    PubMed     Text format     Abstract available


  43. LAN J, Sun L, Xu F, Liu L, et al
    M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer.
    Cancer Res. 2018 Nov 6. pii: 0008-5472.CAN-18-0014.
    PubMed     Text format     Abstract available


    October 2018
  44. LOPES-RAMOS CM, Kuijjer ML, Ogino S, Fuchs CS, et al
    Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
    Cancer Res. 2018;78:5538-5547.
    PubMed     Text format     Abstract available


    September 2018
  45. LIANG J, Chen M, Hughes D, Chumanevich AA, et al
    CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases.
    Cancer Res. 2018 Sep 5. pii: 0008-5472.CAN-18-1583.
    PubMed     Text format     Abstract available



  46. Editor's Note: Zerumbone Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors in Human Colon Cancer Cells: Evidence for an Essential Role of Reactive Oxygen Species.
    Cancer Res. 2018;78:5183.
    PubMed     Text format    


    August 2018
  47. HOGSTROM J, Heino S, Kallio P, Lahde M, et al
    Transcription factor PROX1 suppresses Notch pathway activation via the nucleosome remodeling and deacetylase complex in colorectal cancer stem-like cells.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0451.
    PubMed     Text format     Abstract available


    July 2018
  48. KRISHNAMURTHY A, Dasari A, Noonan AM, Mehnert JM, et al
    Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer.
    Cancer Res. 2018 Jul 24. pii: 0008-5472.CAN-18-0316.
    PubMed     Text format     Abstract available


  49. CHENG J, Dwyer M, Okolotowicz KJ, Mercola M, et al
    A novel inhibitor targets both Wnt signaling and ATM/p53 in colorectal cancer.
    Cancer Res. 2018 Jul 21. pii: 0008-5472.CAN-17-2642.
    PubMed     Text format     Abstract available


  50. CHANG J, Tian J, Yang Y, Zhong R, et al
    A rare missense variant in TCF7L2 associates with colorectal cancer risk by interacting with a GWAS-identified regulatory variant in the MYC enhancer.
    Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-0910.
    PubMed     Text format     Abstract available


  51. VILLARREAL DO, L'Huillier A, Armington S, Mottershead C, et al
    Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in colon cancer.
    Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-1119.
    PubMed     Text format     Abstract available


  52. STEVENS PD, Wen YA, Xiong X, Zaytseva YY, et al
    Erbin suppresses KSR1-mediated RAS/RAF signaling and tumorigenesis in colorectal cancer.
    Cancer Res. 2018 Jul 6. pii: 0008-5472.CAN-17-3629.
    PubMed     Text format     Abstract available


  53. KATHER JN, Charoentong P, Suarez-Carmona M, Herpel E, et al
    High-throughput screening of combinatorial immunotherapies with patient-specific in silico models of metastatic colorectal cancer.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-18-1126.
    PubMed     Text format     Abstract available



  54. Correction: Heterochromatin Protein HP1gamma Promotes Colorectal Cancer Progression and Is Regulated by miR-30a.
    Cancer Res. 2018;78:3741.
    PubMed     Text format    


    June 2018
  55. WANG X, Chan AT, Slattery ML, Chang-Claude J, et al
    Influence of smoking, body mass index and other factors on the preventive effect of nonsteroidal anti-inflammatory drugs on colorectal cancer risk.
    Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-18-0326.
    PubMed     Text format     Abstract available


    May 2018
  56. LOFFLER MW, Kowalewski DJ, Backert L, Bernhardt J, et al
    Mapping the HLA ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.
    Cancer Res. 2018 May 22. pii: 0008-5472.CAN-17-1745.
    PubMed     Text format     Abstract available


  57. ULLMANN P, Rodriguez F, Schmitz M, Meurer SK, et al
    The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis.
    Cancer Res. 2018 May 10. pii: 0008-5472.CAN-17-3003.
    PubMed     Text format     Abstract available


    April 2018
  58. WANG Q, Zhou Y, Rychahou P, Harris JW, et al
    Deptor is a novel target of Wnt/beta-catenin/c-Myc and contributes to colorectal cancer cell growth.
    Cancer Res. 2018 Apr 17. pii: 0008-5472.CAN-17-3107.
    PubMed     Text format     Abstract available


  59. RESAR L, Chia L, Xian L
    Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
    Cancer Res. 2018 Apr 4. pii: 0008-5472.CAN-17-3045.
    PubMed     Text format     Abstract available


  60. CASTLE PE
    Charting the Future of Cancer Health Disparities Research-Letter.
    Cancer Res. 2018;78:1883-1885.
    PubMed     Text format    


  61. SCHWAB A, Siddiqui A, Vazakidou ME, Napoli F, et al
    Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells.
    Cancer Res. 2018;78:1604-1618.
    PubMed     Text format     Abstract available


  62. WALKER-SAMUEL S, Roberts TA, Ramasawmy R, Burrell JS, et al
    Investigating Low-Velocity Fluid Flow in Tumors with Convection-MRI.
    Cancer Res. 2018;78:1859-1872.
    PubMed     Text format     Abstract available


    March 2018
  63. MENG Q, Wu S, Wang Y, Xu J, et al
    MPO promoter polymorphism rs2333227 enhances malignant phenotypes of colorectal cancer by altering the binding affinity of AP-2alpha.
    Cancer Res. 2018 Mar 14. pii: 0008-5472.CAN-17-2538.
    PubMed     Text format     Abstract available


  64. PAQUET-FIFIELD S, Koh SL, Cheng L, Beyit LM, et al
    Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells.
    Cancer Res. 2018 Mar 6. pii: 0008-5472.CAN-17-1869.
    PubMed     Text format     Abstract available


    February 2018
  65. TOMMELEIN J, De Vlieghere E, Verset L, Melsens E, et al
    Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation.
    Cancer Res. 2018;78:659-670.
    PubMed     Text format     Abstract available


  66. CHOWELL D, Napier J, Gupta R, Anderson KS, et al
    Modeling the Subclonal Evolution of Cancer Cell Populations.
    Cancer Res. 2018;78:830-839.
    PubMed     Text format     Abstract available


    January 2018
  67. LIU L, Zhang Y, Wong CC, Zhang J, et al
    RNF6 promotes colorectal cancer by activating the Wnt/beta-catenin pathway via ubiquitination of TLE3.
    Cancer Res. 2018 Jan 26. pii: 0008-5472.CAN-17-2683.
    PubMed     Text format     Abstract available


  68. YAN TT, Ren LL, Shen CQ, Wang ZH, et al
    MicroRNA-508 defines the stem-like/mesenchymal subtype in colorectal cancer.
    Cancer Res. 2018 Jan 26. pii: 0008-5472.CAN-17-2101.
    PubMed     Text format     Abstract available


  69. YANG X, Wang Z, Li X, Liu B, et al
    SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
    Cancer Res. 2018;78:372-386.
    PubMed     Text format     Abstract available


    December 2017
  70. HANKEY WC, McIlhatton MA, Ebede K, Kennedy B, et al
    Mutational mechanisms that activate Wnt signaling and predict outcomes in colorectal cancer patients.
    Cancer Res. 2017 Dec 6. pii: 0008-5472.CAN-17-1357.
    PubMed     Text format     Abstract available



  71. Correction: miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4.
    Cancer Res. 2017;77:6788.
    PubMed     Text format    


  72. YAEGER R, Yao Z, Hyman DM, Hechtman JF, et al
    Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition.
    Cancer Res. 2017;77:6513-6523.
    PubMed     Text format     Abstract available


    November 2017
  73. EMERSON MA, Banegas MP, Chawla N, Achacoso N, et al
    Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0429.
    PubMed     Text format     Abstract available


  74. YAU EH, Kummetha IR, Lichinchi G, Tang R, et al
    Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers.
    Cancer Res. 2017;77:6330-6339.
    PubMed     Text format     Abstract available



  75. Correction: A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer.
    Cancer Res. 2017;77:6048.
    PubMed     Text format    


    October 2017
  76. LULLA AR, Slifker MJ, Zhou Y, Lev A, et al
    miR-6883 family miRNAs target CDK4/6 to induce G1 phase cell cycle arrest in colon cancer cells.
    Cancer Res. 2017 Oct 23. pii: canres.1767.2017.
    PubMed     Text format     Abstract available


  77. KIM SY, Jung JH, Lee HJ, Soh H, et al
    [18F]fluorothymidine positron emission tomography informs the synergistic efficacy of capecitabine and trifluridine/tipiracil in colon cancer.
    Cancer Res. 2017 Oct 20. pii: canres.1406.2017.
    PubMed     Text format     Abstract available


  78. HUANG S, Fantini D, Merrill B, Bagchi S, et al
    DDB2 is a Novel Regulator of Wnt-Signaling in Colon Cancer.
    Cancer Res. 2017 Oct 11. pii: canres.1570.2017.
    PubMed     Text format     Abstract available


  79. TANG YC, Yuwen H, Wang K, Bruno PM, et al
    Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis.
    Cancer Res. 2017;77:5272-5286.
    PubMed     Text format     Abstract available


    September 2017
  80. KIDDER BL, He R, Wangsa D, Padilla-Nash HM, et al
    SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation.
    Cancer Res. 2017 Sep 26. pii: canres.0828.2017.
    PubMed     Text format     Abstract available


  81. ZHOU X, Geng L, Wang D, Yi H, et al
    R-Spondin1/LGR5 Activates TGFbeta Signaling and Suppresses Colon Cancer Metastasis.
    Cancer Res. 2017 Sep 22. pii: canres.0219.2017.
    PubMed     Text format     Abstract available


  82. KATHER JN, Poleszczuk J, Suarez-Carmona M, Krisam J, et al
    In silico modeling of immunotherapy and stroma-targeting therapies in human colorectal cancer.
    Cancer Res. 2017 Sep 18. pii: canres.2006.2017.
    PubMed     Text format     Abstract available


  83. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    PubMed     Text format     Abstract available


  84. TAKADA M, Zhang W, Suzuki A, Kuroda TS, et al
    FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A.
    Cancer Res. 2017;77:4881-4893.
    PubMed     Text format     Abstract available


    August 2017
  85. ZHAO Y, Ting KK, Li J, Cogger VC, et al
    Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell-Mediated Immunotherapy.
    Cancer Res. 2017;77:4434-4447.
    PubMed     Text format     Abstract available


  86. MARELLI G, Erreni M, Anselmo A, Taverniti V, et al
    Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.
    Cancer Res. 2017;77:4472-4485.
    PubMed     Text format     Abstract available


    July 2017
  87. JERMYN M, Mercier J, Aubertin K, Desroches J, et al
    Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.
    Cancer Res. 2017;77:3942-3950.
    PubMed     Text format     Abstract available


    May 2017
  88. VISWANATHAN V, Damle S, Zhang T, Opdenaker LM, et al
    An miRNA expression signature for the human colonic stem cell niche distinguishes malignant from normal epithelia.
    Cancer Res. 2017 May 9. pii: canres.2388.2016.
    PubMed     Text format     Abstract available


  89. LANG M, Berry D, Passecker K, Mesteri I, et al
    HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
    Cancer Res. 2017;77:2424-2438.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: